April 2022 Written by: Mohsin H. Ali, MD Retina Group of Washington Washington D.C. Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Efficacy, durability, […]
April 2022 Written by: Akshay Thomas, M.D. Tennessee Retina Nashville, TN Khanani AM, Zarbin MA, Barakat MR, et al. Safety outcomes of brolucizumab in neovascular age-related macular degeneration: results from the iris registry and komodo healthcare map. JAMA Ophthalmol. 2022;140(1):20-28. Treatment options for wet AMD include off-label use of bevacizumab or use of an FDA-approved […]
April 2022 Written by: Vlad Matei, M.D. Rocky Mountain Retina Associates Boulder, CO Marlow E, Hassan T, Faia L, et al. Vitrectomy for symptomatic asteroid hyalosis. J Vitreoretin Dis 2021;5(5):420-424. Asteroid hyalosis (AH) is a common and benign degeneration consisting of calcium- and lipid-rich opacities, termed asteroid bodies (ABs), accumulating in the vitreous gel. Until […]
March 2022 Written by: Katherine E. Talcott, MD Cole Eye Institute Cleveland Clinic Azad AD, Chandramohan A, Li AS, Rosenblatt TR, Reeves M-GR, Pasricha MV, Ludwig CA, Nguyen A, Winges KM, Wang SY, Pan CK, Moss HE, Do DV, Fountain TR, Kossler AL, Representation of Women in Ophthalmology Subspecialty Societies over 20 Years, Ophthalmology (2022), […]
March 2022 Written by: Maxwell Stem, MD Pennsylvania Retina Specialists, PC Gretchenig C, Reiter GS, Riedl S, Arnold J, Guymer R, Gerendas BS, Bogunovic H, Schmidt-Erfurth U. Impact of Residual Subretinal Fluid Volumes on Treatment Outcomes in a Subretinal Fluid-Tolerant Treat-and-Extend Regimen. Retina. 2021;41(11):2221-2228. The axiom that the goal of anti-VEGF therapy is to completely […]
February 2022 Written by: Nika Bagheri, MD California Retina Consultants and Research Foundation Santa Barbara, CA Holekamp NM, Campochiaro PA, Chang M, Miller D, Pieramici D, Adamis AP, Brittain C, Evans E, Kaufman D, Maass KF, Patel S, Ranade S, Singh N, Barteselli G, Regillo C, on behalf of all Archway Investigators. ARCHWAY: Randomized […]
February 2022 Written by: Christian Sanfilippo, MD The Retina Partners Los Angeles, CA Lee WW, Bansal A, Sadda S, Sarraf D, Berger AR, Wong DT, Kertes PJ, Kohly RP, Hillier RJ, Muni RH. Outer Retinal Folds Following Pars Plana Vitrectomy vs Pneumatic Retinopexy for Retinal Detachment Repair: Post Hoc Analysis from PIVOT. Ophthalmol Retina. 2021 […]
January 2022 Written by: Rehan Hussain, MD Retina Health Institute Elgin, IL Meyer BI, Berry DE, Cribbs BE, et al. Outcomes of Infectious Endophthalmitis in Patients with Systemic Antibiotic Allergies to Penicillins, Cephalosporins, or Vancomycin. Ophthalmol Retina 2021 Sep;5(9):901-909 Infectious endophthalmitis is a rare but potentially visually devastating issue that requires prompt diagnosis […]
